TY - STAND
AU - K. Filion
AU - A. Douros
AU - L. Azoulay
AU - H. Yin
AU - O. Yu
AU - S. Suissa
BT - Br J Clin Pharmacol
DO - 10.1111/bcp.14056
PY - 2019
T2 - Br J Clin Pharmacol
TI - Sulfonylureas as initial treatment for type 2 diabetes and the risk of adverse cardiovascular events: A population-based cohort study
SN - 0306-5251
ER -